Foundation Medicine
Healthcare AI
Genomic profiling / precision oncology diagnostics
Acquired
Foundation Medicine is a molecular diagnostics company focused on genomic profiling for cancer, developing and selling next-generation sequencing-based assays that help identify genomic alterations to guide personalized oncology care. It operates as a Roche subsidiary and is positioned in precision oncology rather than a broad AI healthcare software company, though it may use computational methods in its testing and analytics workflows.
Company Details
- Website
- foundationmedicine.com
- Headquarters
- Boston, Massachusetts, United States
- Founded
- 2010
- Funding
- $96.5M (reported VC funding); additional acquisition/transaction value not included
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring